Peptide TherapeuticsPeer Reviewed

Estimating disorder probability based on polygenic prediction using the BPC approach.

Authors (4)
Emil UffelmannDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. e.uffelmann@vu.nl.
Alkes L Price
Danielle Posthuma
Wouter J Peyrot
Nature communications
Unknown
Published
Oct 13, 2025
View Original

Abstract

Polygenic Scores (PGSs) summarize an individual's genetic propensity for a given trait. Bayesian methods, which improve the prediction accuracy of PGSs, are not well-calibrated for binary disorder traits in ascertained samples. This is a problem because well-calibrated PGSs are needed for future clinical implementation. We introduce the Bayesian polygenic score Probability Conversion (BPC) approach, which computes an individual's predicted disorder probability using genome-wide association study summary statistics, an existing Bayesian PGS method (e.g. PRScs, SBayesR), the individual's genotype data, and a prior disorder probability (which can be specified flexibly, based for example on literature, small reference samples, or prior elicitation). The BPC approach is practical in its application as it does not require a tuning sample with both genotype and phenotype data. Here, we show in simulated and empirical data of nine disorder traits that BPC yields well-calibrated results that are consistently better than the results of another recently published approach.

Keywords

Multifactorial InheritanceGenome-Wide Association StudyHumansBayes TheoremProbabilityModels, GeneticGenotypePhenotypeGenetic Predisposition to DiseaseComputer Simulation

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics